Remifentanil in Children With Obstructive Sleep Apnea
Status:
Completed
Trial end date:
2017-10-31
Target enrollment:
Participant gender:
Summary
This investigation tested the hypothesis that children with obstructive sleep apnea have an
increased pharmacodynamic sensitivity to the miotic and respiratory depressant effects of the
prototypic μ-opioid agonist remifentanil.